Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2026
Employees
74,000
Stocks News & Analysis
stocks
Earnings margins to improve for mining specialist
stocks
Nvidia: Hugging Face acquisition both a wise offensive and defensive move
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,202.60 | 10.10 | -0.11% |
| CAC 40 | 8,278.77 | 7.63 | -0.09% |
| DAX 40 | 26,046.40 | 43.08 | 0.17% |
| Dow JONES (US) | 53,414.25 | 271.86 | -0.51% |
| FTSE 100 | 10,831.09 | 0.43 | -0.00% |
| HKSE | 25,414.95 | 235.92 | -0.92% |
| NASDAQ | 26,506.99 | 77.07 | -0.29% |
| Nikkei 225 | 66,460.11 | 1,439.17 | 2.21% |
| NZX 50 Index | 13,921.42 | 52.76 | -0.38% |
| S&P 500 | 7,718.60 | 29.11 | -0.38% |
| S&P/ASX 200 | 9,010.80 | 12.60 | -0.14% |
| SSE Composite Index | 3,930.95 | 0.83 | 0.02% |